AF
Advent France Biotechnology
Micro VCActiveA venture capital fund supported in particular by the National Seed-Fund.
10
Investments
2
Exits
€100M
AUM
20.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Advent France Biotechnology.
Investment Thesis & Strategy
Advent France Biotechnology invests in various stages of companies across the general biotechnology sector, with a focus on early-stage ventures. They are supported by the National Seed-Fund.
Investment Activity
Deals per year over the last 11 years
1
20100
20110
20121
20130
20142
20152
20161
20170
20180
20191
2020Portfolio Companies
Selected investments from their portfolio of 10 companies
I
InHeart
Biotech · Series A, 2020
H
Horama
Biotech · Series A, 2017
S
Stilla Technologies
Biotech · Series A, 2016
I
ImCheck Therapeutics
Biotech · Series A, 2016
T
TissUse
Biotech · Series A, 2015
O
OSE Immunotherapeutics
Biotech · Series A, 2015
P
Pixium Vision
Biotech · Growth, 2013
I
Innate Pharma
Biotech · Growth, 2010
Notable Exits
CompanyTypeYearValue / Acquirer
Stilla TechnologiesAcquisition2024—
Innate PharmaIPO2006—
Frequently Asked Questions
Advent France Biotechnology focuses on Seed, Series A stage investments.